CONMED Corp — Director's Dealing 2019

Dec 5, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2019-12-04

Reporting Person: KENNEDY JOHN JED (VP GM CET)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-12-04	Common Stock	M	14820	$39.87	Acquired	19317	Direct
2019-12-04	Common Stock	F	8432	$114.81	Disposed	10885	Direct
2019-12-04	Common Stock	M	10000	$41.93	Acquired	20885	Direct
2019-12-04	Common Stock	F	6469	$114.92	Disposed	14416	Direct
2019-12-04	Common Stock	M	5400	$59.96	Acquired	19816	Direct
2019-12-04	Common Stock	F	3965	$114.92	Disposed	15851	Direct
2019-12-04	Common Stock	S	11354	$115.03	Disposed	4497	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-12-04	Options To Purchase Common Stock	$39.87	M	14820	Disposed	2026-03-01	Common Stock (14820)	Direct
2019-12-04	Options To Purchase Common Stock	$41.93	M	10000	Disposed	2027-03-01	Common Stock (10000)	Direct
2019-12-04	Options To Purchase Common Stock	$59.96	M	5400	Disposed	2028-03-01	Common Stock (5400)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $114.66 to $115.41. Full information regarding the number of shares sold at each separate price will be provided upon request of the Commission staff, CONMED, or a CONMED security holder.

F2: The stock options were granted under the Company's 2015 Amended and Restated Long-Term Incentive Plan and generally vest in equal amounts over a five year period